Sarisozen, Can <br/><br/>
Nanomedicine based curcumin and doxorubicin combination treatment of glioblastoma with scFv-targeted micelles: In vitro evaluation on 2D and 3D tumor models.  [electronic resource] 

 -  European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V  Nov 2016 
 - 54-67 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1873-3441 
<br/><br/><label>Standard No.: </label>10.1016/j.ejpb.2016.08.013  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antineoplastic Agents--administration & dosage<br/>Biotinylation<br/>Blood-Brain Barrier<br/>Cell Line, Tumor--drug effects<br/>Curcumin--administration & dosage<br/>Doxorubicin--administration & dosage<br/>Drug Carriers--chemistry<br/>Drug Delivery Systems--methods<br/>Drug Evaluation, Preclinical<br/>Drug Resistance, Neoplasm--drug effects<br/>Flow Cytometry<br/>Glioblastoma--metabolism<br/>Glucose Transporter Type 1--metabolism<br/>Humans<br/>Ligands<br/>Micelles<br/>NF-kappa B--antagonists & inhibitors<br/>Nanomedicine--methods<br/>Neoplasms--pathology<br/>Phenotype<br/>Polymers<br/>Prognosis<br/>Single-Chain Antibodies--chemistry<br/>Spheroids, Cellular